These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 35137398)

  • 61. Survival determinants in lung transplant patients with chronic allograft dysfunction.
    Verleden GM; Vos R; Verleden SE; De Wever W; De Vleeschauwer SI; Willems-Widyastuti A; Scheers H; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transplantation; 2011 Sep; 92(6):703-8. PubMed ID: 21836537
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction.
    Misumi K; Wheeler DS; Aoki Y; Combs MP; Braeuer RR; Higashikubo R; Li W; Kreisel D; Vittal R; Myers J; Lagstein A; Walker NM; Farver CF; Lama VN
    JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268593
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Kneidinger N; Milger K; Janitza S; Ceelen F; Leuschner G; Dinkel J; Königshoff M; Weig T; Schramm R; Winter H; Behr J; Neurohr C
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404648
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic effect of ischemia-reperfusion injury upon primary graft dysfunction and chronic lung allograft dysfunction in lung transplantation: evidence based on transcriptome data.
    Zheng XY; Huang H; Wei ZT; Yan HJ; Wang XW; Xu L; Li CH; Tang HT; Wang JJ; Yu ZW; Tian D
    Transpl Immunol; 2022 Apr; 71():101556. PubMed ID: 35202801
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The diagnosis and management of chronic lung allograft dysfunction.
    Verleden GM; Hendriks JMH; Verleden SE
    Curr Opin Pulm Med; 2024 Jul; 30(4):377-381. PubMed ID: 38305383
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activation of Humoral Immunity during the Pathogenesis of Experimental Chronic Lung Allograft Dysfunction.
    Reichert M; Atanasova S; Petri K; Kampschulte M; Kojonazarov B; Fuchs-Moll G; Krombach GA; Padberg W; Grau V
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897686
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.
    Fisher CE; Preiksaitis CM; Lease ED; Edelman J; Kirby KA; Leisenring WM; Raghu G; Boeckh M; Limaye AP
    Clin Infect Dis; 2016 Feb; 62(3):313-319. PubMed ID: 26565010
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G.
    Brugière O; Mouren D; Trichereau J; Vallée A; Kuzniak I; Hirschi S; Renaud-Picard B; Reynaud-Gaubert M; Nieves A; Bunel V; Messika J; Demant X; Macey J; Le Pavec J; Dauriat G; Saint-Raymond C; Falque L; Mornex JF; Tissot A; Foureau A; Borgne Krams AL; Bousseau V; Magnan A; Picard C; Roux A; Carosella E; LeMaoult J; Rouas-Freiss N;
    J Heart Lung Transplant; 2022 May; 41(5):626-640. PubMed ID: 35181243
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Noninvasive methods for detection of chronic lung allograft dysfunction in lung transplantation.
    Tian D; Huang H; Wen HY
    Transplant Rev (Orlando); 2020 Jul; 34(3):100547. PubMed ID: 32498976
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States.
    Sheshadri A; Sacks NC; Healey B; Cyr P; Boerner G; Huang HJ
    J Med Econ; 2022; 25(1):650-659. PubMed ID: 35502563
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunological Landscapes in Lung Transplantation: Insights from T Cell Profiling in BAL and PBMC.
    de Silva TA; Apte S; Voisey J; Spann K; Tan M; Chambers D; O'Sullivan B
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473722
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association between the renin-angiotensin system and chronic lung allograft dysfunction.
    Berra G; Farkona S; Mohammed-Ali Z; Kotlyar M; Levy L; Clotet-Freixas S; Ly P; Renaud-Picard B; Zehong G; Daigneault T; Duong A; Batruch I; Jurisica I; Konvalinka A; Martinu T
    Eur Respir J; 2021 Oct; 58(4):. PubMed ID: 33863738
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel biomarkers of chronic lung allograft dysfunction: is there anything reliable?
    Verleden SE; Verleden GM
    Curr Opin Organ Transplant; 2022 Feb; 27(1):1-6. PubMed ID: 34939958
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Donor surfactant protein D (SP-D) polymorphisms are associated with lung transplant outcome.
    Aramini B; Kim C; Diangelo S; Petersen E; Lederer DJ; Shah L; Robbins H; Floros J; Arcasoy SM; Sonett JR; D'Ovidio F
    Am J Transplant; 2013 Aug; 13(8):2130-6. PubMed ID: 23841811
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Importance of the preoperative prognostic nutritional index score as a predictor of chronic lung allograft dysfunction after lung transplantation: a Japanese single-institution study.
    Kanou T; Minami M; Funaki S; Ose N; Fukui E; Kimura K; Shintani Y
    Surg Today; 2021 Dec; 51(12):1946-1952. PubMed ID: 33839934
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Chronic Lung Allograft Dysfunction after Living-donor Lobar Lung Transplantation].
    Sugimoto S; Tanaka S; Miyoshi K; Toyooka S
    Kyobu Geka; 2022 Apr; 75(4):297-301. PubMed ID: 35342161
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Significance of phenotype change after chronic lung allograft dysfunction onset.
    Fuchs E; Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Ghany R; Havlin J; McInnis MC; Keshavjee S; Singer LG; Tikkanen J; Chow CW; Martinu T
    Transpl Int; 2021 Dec; 34(12):2620-2632. PubMed ID: 34748217
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells.
    Siemeni T; Knöfel AK; Ius F; Sommer W; Salman J; Böthig D; Falk CS; Tudorache I; Haverich A; Warnecke G
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2528-2537. PubMed ID: 30955963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.